Capital Research Global Investors
BLUE

Capital Research Global Investors’s bluebird bio BLUE Stock Holding History

Capital Research Global Investors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-627,504
Closed -$352M – 427
2020
Q4 		$352M Buy
627,504
+2,236
+0.4% +$1.42M 0.09% 183
2020
Q3 		$437M Buy
625,268
+352
+0.1% +$275K 0.13% 150
2020
Q2 		$494M Buy
624,916
+98,998
+19% +$74.7M 0.16% 136
2020
Q1 		$313M Buy
525,918
+2,569
+0.5% +$2.5M 0.12% 145
2019
Q4 		$595M Buy
523,349
+467
+0.1% +$508K 0.18% 116
2019
Q3 		$622M Buy
522,882
+7,462
+1% +$11.4M 0.2% 109
2019
Q2 		$849M Buy
515,420
+154
+0% +$266K 0.27% 87
2019
Q1 		$1.05B Sell
515,266
-1,930
-0.4% -$3.4M 0.33% 66
2018
Q4 		$665M Buy
517,196
+5,027
+1% +$7.71M 0.23% 90
2018
Q3 		$969M Buy
512,169
+38,197
+8% +$78.9M 0.28% 73
2018
Q2 		$964M Buy
473,972
+1,278
+0.3% +$2.91M 0.26% 92
2018
Q1 		$1.05B Buy
472,694
+8,659
+2% +$22M 0.3% 87
2017
Q4 		$1.07B Buy
464,035
+32,903
+8% +$66.8M 0.31% 81
2017
Q3 		$767M Buy
431,132
+7,835
+2% +$10.9M 0.23% 112
2017
Q2 		$576M Buy
423,297
+38,066
+10% +$45.9M 0.18% 128
2017
Q1 		$454M Buy
385,231
+21,384
+6% +$21.8M 0.14% 151
2016
Q4 		$291M Buy
363,847
+55,602
+18% +$44.2M 0.09% 191
2016
Q3 		$271M Sell
308,245
-40,980
-12% -$29.7M 0.09% 192
2016
Q2 		$196M Buy
349,225
+302
+0.1% +$171K 0.07% 222
2016
Q1 		$192M Buy
348,923
+5,171
+2% +$3.18M 0.07% 229
2015
Q4 		$286M Buy
343,752
+807
+0.2% +$806K 0.1% 187
2015
Q3 		$380M Buy
342,945
+4,662
+1% +$8.5M 0.14% 157
2015
Q2 		$738M Buy
338,283
+30,303
+10% +$61.7M 0.24% 102
2015
Q1 		$482M Buy
307,980
+8,744
+3% +$11.5M 0.16% 136
2014
Q4 		$356M Buy
299,236
+28,811
+11% +$19.3M 0.12% 184
2014
Q3 		$126M Buy
270,425
+38,615
+17% +$17.8M 0.04% 274
2014
Q2 		$116M Buy
231,810
+3,240
+1% +$1.04M 0.04% 279
2014
Q1 		$67.3M Buy
228,570
+26,862
+13% +$8.14M 0.02% 317
2013
Q4 		$54.8M Buy
201,708
+122,038
+153% +$34.1M 0.02% 330
2013
Q3 		$27.8M Buy
+79,670
New +$29.6M 0.01% 381

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Capital Research Global Investors's BLUE Position: Q1 2021 in Review

Capital Research Global Investors sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 627,504 shares — an estimated $352M sold.

Capital Research Global Investors first reported a position in BLUE in Q3 2013 and held it in 30 quarters. The position peaked at $1.07B in Q4 2017. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Capital Research Global Investors reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Capital Research Global Investors sold 627,504 bluebird bio shares in Q1 2021, an estimated $352M.
  • Capital Research Global Investors first reported a position in bluebird bio in Q3 2013 and held it in 30 quarters.
  • Capital Research Global Investors's bluebird bio position peaked at $1.07B in Q4 2017.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Capital Research Global Investors's 13F filing for Q1 2021, filed 14 May 2021.